These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia. Tsuda E; Imai T; Matsumura A; Hisahara S; Nonaka M; Shiraishi H; Motomura M; Shimohama S Intern Med; 2008; 47(5):445-7. PubMed ID: 18310980 [TBL] [Abstract][Full Text] [Related]
26. [Morphological findings in the thymus gland in adynamic hyperthyroidism]. Selberg W Med Klin; 1968 Aug; 63(32):1253-4. PubMed ID: 5722901 [No Abstract] [Full Text] [Related]
27. Thymic hyperplasia and Graves disease: management of anterior mediastinal masses in patients with Graves disease. Yacoub A; Gaitonde DY; Wood JC Endocr Pract; 2009; 15(6):534-9. PubMed ID: 19491074 [TBL] [Abstract][Full Text] [Related]
28. [Therapy of acute thyrotoxic attacks]. Laroche C; Grégoire J; Turpin G Presse Med (1893); 1968 Dec; 76(48):2283-5. PubMed ID: 4181047 [No Abstract] [Full Text] [Related]
29. Graves' disease, thymus enlargement, and hypercalcemia. Giovanella L; Suriano S; Ceriani L N Engl J Med; 2008 Mar; 358(10):1078-9. PubMed ID: 18322294 [No Abstract] [Full Text] [Related]
30. Immunoglobulins that cause thymocyte proliferation from a patient with Graves' disease and an enlarged thymus. Wortsman J; McConnachie P; Baker JR; Burman KD Am J Med; 1988 Jul; 85(1):117-21. PubMed ID: 3260449 [No Abstract] [Full Text] [Related]
31. Anterior mediastinal mass in a patient with Graves' disease. Yamanaka K; Nakayama H; Watanabe K; Kameda Y Ann Thorac Surg; 2006 May; 81(5):1904-6. PubMed ID: 16631707 [TBL] [Abstract][Full Text] [Related]
32. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease]. Letonturier P; Tourneur R; Sénécal P Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703 [No Abstract] [Full Text] [Related]
34. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct. Gharib H; Mayberry WE Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249 [No Abstract] [Full Text] [Related]
36. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
37. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Alpert LI; Papatestas A; Kark A; Osserman RS; Osserman K Arch Pathol; 1971 Jan; 91(1):55-61. PubMed ID: 4922629 [No Abstract] [Full Text] [Related]
38. Thymic uptake of gallium in a patient with unsuspected hyperthyroidism. Mele F; Forman B; Caride VJ AJR Am J Roentgenol; 1996 Feb; 166(2):450-1. PubMed ID: 8553965 [No Abstract] [Full Text] [Related]
39. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator. Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552 [No Abstract] [Full Text] [Related]
40. [Treatment of T3-predominant Graves' disease]. Lin LX Zhonghua Yi Xue Za Zhi; 1988 Feb; 68(2):79-81. PubMed ID: 2457417 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]